Key facts
- NourishedRx’s last known valuation is $50.0M (Jul 2025).
- It has raised $25.6M; the latest was Later Stage VC ($15.0M) in Jul 2025.
- Notable investors include Connecticut Innovations, S2G Investments, PeakBridge, HDS Capital, Primetime Partners — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for NourishedRx
- ·The full record, as it builds
Funding rounds
No funding rounds for NourishedRx are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About NourishedRx
Developer of a personalized nutrition and wellness platform designed for supporting individual health optimization. The company's platform combines at-home nutrient testing, AI-driven analysis of dietary and lifestyle data, formulation of custom micronutrient packs, integration with user health profiles, progress tracking, and feedback loops to adjust recommendations over time, enabling health-conscious consumers and wellness practitioners to tailor supplementation and lifestyle interventions based on individual biomarkers and goals.
- Sector
- Healthcare
- HQ
- Stamford, CT, United States
- Founded
- 2019
- Employees
- 48
- Website
- nourishedrx.com/
- Ownership
- Privately Held (backing)
NourishedRx doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in NourishedRx shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on NourishedRx in its N-PORT filings yet. We sweep new filings monthly.